Concourse Financial Group Securities, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share
Q3 2022 Nov 15, 2022	BUY	$0.08 - $21.0 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.16 - $0.47 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.42 - $0.62 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$0.56 - $1.71 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.8 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $0 - $0
Q1 2021 May 13, 2021	BUY	$1.36 - $2.49 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$0.75 - $2.76 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.17 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$0.47 - $0.72 $0 - $0
Q1 2020 May 13, 2020	BUY	$0.36 - $0.74 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$0.35 - $0.58 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$0.38 - $0.52 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$0.39 - $0.7 $0 - $0
Q1 2019 May 15, 2019	BUY	$0.43 - $0.68 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$0.44 - $3.02 $0 - $0

Others Institutions Holding AMPE

# of Institutions

Shares Held

96.6K

Call Options Held

Put Options Held

Ntb Financial Corp Centennial, CO

96.6K
Shares

$965
0.01% of portfolio

View Full List

About Ampio Pharmaceuticals, Inc.

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

More about AMPE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account